Maryland sells MINI 44.22: Photo Release -- NASDAQ Welcomes Intersect ENT (NASDAQ: XENT) to The NASDAQ Stock Market
NEW YORK, July 24, 2014 (GLOBE NEWSWIRE) -- The NASDAQ OMX Group, Inc. (NDAQ ... Intersect ENT's initial products, PROPEL and PROPEL mini, are the first and only drug-eluting implants approved for use in patients with chronic sinusitis. ...
30 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home